ABOUT 180MG MDMA

In its software, Lykos describes MDMA as being a catalyst for the therapeutic method, Which explains why it received a lot interest. That's not predicted being just as much of the hold-up for other psychedelics, however. “The remainder of us are researching molecules that don't have to have precisely the same degree of therapy,” suggests Kabir